Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kun Yu

Showing results (981-990 of 1,009) with videos related to

Pageof 101
Sort By:
Redox Biology|September 24, 2019
Covalent Aurora A regulation by the metabolic integrator coenzyme AYugo Tsuchiya, Dominic P Byrne, Selena G Burgess, et al.
Nature Communications|November 20, 2014
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencingSwee Seong Wong, Kyoung-Mee Kim, Jason C Ting, et al.
Cancer Cell|November 16, 2016
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5Hui-Lung Sun, Ri Cui, JianKang Zhou, et al.
JCI Insight|January 19, 2021
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Emine G Gunes, Keren David, et al.
Cell Reports. Medicine|February 12, 2025
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinomaWei Jiang, Gao-Yuan Wang, Guan-Jie Qin, et al.
Chinese Medicine|October 17, 2025
Omics-based profiling and therapeutic potential of natural components in pan-Shennongjia medicinal herbsJun Song, Chong Yuan, Fei Wang, et al.
Molecular Cancer Research : MCR|August 31, 2017
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based SubtypesLi Zhang, Kenzie D MacIsaac, Ting Zhou, et al.
Cancer Cell|February 28, 2025
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialCheng Xu, Guan-Qun Zhou, Wen-Fei Li, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
Med (New York, N.Y.)|February 14, 2026
Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinomaCheng Xu, Ze-Qi Lin, Yu-Zhe Wang, et al.
Pageof 101

Showing results (981-990 of 1,009) with videos related to

Sort By:
Pageof 101
Redox Biology|September 24, 2019
Covalent Aurora A regulation by the metabolic integrator coenzyme AYugo Tsuchiya, Dominic P Byrne, Selena G Burgess, et al.
Nature Communications|November 20, 2014
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencingSwee Seong Wong, Kyoung-Mee Kim, Jason C Ting, et al.
Cancer Cell|November 16, 2016
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5Hui-Lung Sun, Ri Cui, JianKang Zhou, et al.
JCI Insight|January 19, 2021
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Emine G Gunes, Keren David, et al.
Cell Reports. Medicine|February 12, 2025
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinomaWei Jiang, Gao-Yuan Wang, Guan-Jie Qin, et al.
Chinese Medicine|October 17, 2025
Omics-based profiling and therapeutic potential of natural components in pan-Shennongjia medicinal herbsJun Song, Chong Yuan, Fei Wang, et al.
Molecular Cancer Research : MCR|August 31, 2017
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based SubtypesLi Zhang, Kenzie D MacIsaac, Ting Zhou, et al.
Cancer Cell|February 28, 2025
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialCheng Xu, Guan-Qun Zhou, Wen-Fei Li, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
Med (New York, N.Y.)|February 14, 2026
Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinomaCheng Xu, Ze-Qi Lin, Yu-Zhe Wang, et al.
Pageof 101